[1]
2025. Real-World Treatment Outcomes and Safety Profiles of Tyrosine Kinase Inhibitors in Iraqi Patients with Chronic Myeloid Leukemia. Medical Forum Monthly. 36, 8 (Sep. 2025). DOI:https://doi.org/10.60110/medforum.360807.